2001
DOI: 10.1592/phco.21.12.124s.34511
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal Resistance Among Candida Species

Abstract: Isolation of Candida sp less susceptible to traditional therapies and recovery of increasingly resistant isolates during antifungal therapy are growing problems. It is important for clinicians to be aware of trends and mechanisms responsible for the expression of resistance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
26
0
1

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(28 citation statements)
references
References 88 publications
1
26
0
1
Order By: Relevance
“…The most common treatment is the use of antifungal agents, such as azoles (fluconazole, itraconazole, miconazole and ketoconazole) and polyenes (amphotericin B or nystatin). The control of the infections caused by Candida faces several problems, including the limited number of effective antifungal agents, their high toxicity and costs, the recurrence of the infection and, mainly, the increasing resistance to them [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…The most common treatment is the use of antifungal agents, such as azoles (fluconazole, itraconazole, miconazole and ketoconazole) and polyenes (amphotericin B or nystatin). The control of the infections caused by Candida faces several problems, including the limited number of effective antifungal agents, their high toxicity and costs, the recurrence of the infection and, mainly, the increasing resistance to them [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Immunocompromised individuals, such as AIDS and cancer patients, neonates, organ transplant recipients, and patients with indwelling catheters, can develop disseminated candidiasis, a systemic form of the disease with an approximately 40% mortality rate (2,4,5). Candida infections have become more difficult to treat due to a limited number of antifungal therapies and increased frequency of drug-resistant isolates (6,7).…”
mentioning
confidence: 99%
“…are more common in serious fungal infections our results showed exactly the opposite, i.e. C. albicans was the dominant cause (62.5%) of CBSI [15,16]. CBSI caused by C. lipolytica and C. lusitaniae were rarely reported and accounted for only 7% of all detected CBSI [17,18] [2,19,20].…”
Section: Discussionmentioning
confidence: 55%
“…This finding is in accordance with the up to now suggested emergence of resistance towards azole derivatives. Resistance occurrence is still not clear and it can be the consequence of several processes such as appearance of resistant variants from a common genotype, selection of strains from mixed population and reinfection with a resistant subtype [15].…”
Section: Discussionmentioning
confidence: 99%